8/1/2023, 12:33 PM (Source: TeleTrader)
more TeleTrader news


Chart for: MERCK KGAA O.N.

Merck posts Q2 sales of $15B, rising 3%

Merck & Co. Inc. reported on Tuesday that its sales in the second quarter grew by 3% from the same period in 2022, reaching $15 billion and exceeding expectations. The company posted a net loss of $5.9 billion, compared to an income of $3.9 billion in Q2 2022, with a loss per share of $2.35. Merck now forecasts its full-year sales will be in the range between $58.6 billion and $59.6 billion.

"We continue to make great progress as we advance our broad and deep pipeline, raise the bar of innovation, and bring forward leading-edge science to save and improve lives around the world," CEO Robert Davis said. "We delivered robust underlying growth during the second quarter and are well positioned to achieve strong full-year results."

Merck's shares gained 0.44% in premarket trade.

Baha Breaking News (BBN) / DJ